Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 16 studies | 63% ± 17% | |
endothelial cell | 15 studies | 29% ± 12% | |
astrocyte | 14 studies | 31% ± 12% | |
glutamatergic neuron | 12 studies | 39% ± 22% | |
oligodendrocyte precursor cell | 12 studies | 44% ± 15% | |
macrophage | 12 studies | 33% ± 14% | |
microglial cell | 11 studies | 38% ± 10% | |
GABAergic neuron | 9 studies | 38% ± 15% | |
neuron | 7 studies | 39% ± 18% | |
interneuron | 6 studies | 43% ± 12% | |
myeloid cell | 6 studies | 27% ± 10% | |
dendritic cell | 6 studies | 22% ± 4% | |
Mueller cell | 6 studies | 34% ± 11% | |
epithelial cell | 5 studies | 30% ± 15% | |
monocyte | 5 studies | 32% ± 6% | |
fibroblast | 5 studies | 25% ± 7% | |
type II pneumocyte | 5 studies | 21% ± 6% | |
glial cell | 4 studies | 29% ± 12% | |
granule cell | 4 studies | 32% ± 8% | |
club cell | 4 studies | 28% ± 8% | |
endothelial cell of lymphatic vessel | 4 studies | 23% ± 1% | |
adipocyte | 4 studies | 24% ± 4% | |
GABAergic interneuron | 3 studies | 27% ± 9% | |
progenitor cell | 3 studies | 30% ± 6% | |
mononuclear phagocyte | 3 studies | 20% ± 2% | |
ciliated cell | 3 studies | 19% ± 3% | |
GABAergic amacrine cell | 3 studies | 23% ± 5% | |
amacrine cell | 3 studies | 25% ± 5% | |
glycinergic amacrine cell | 3 studies | 24% ± 6% | |
hepatocyte | 3 studies | 37% ± 14% | |
B cell | 3 studies | 25% ± 6% | |
T cell | 3 studies | 18% ± 2% | |
alveolar macrophage | 3 studies | 35% ± 10% | |
natural killer cell | 3 studies | 19% ± 2% | |
type I pneumocyte | 3 studies | 22% ± 6% | |
lymphocyte | 3 studies | 26% ± 5% | |
basal cell | 3 studies | 31% ± 19% | |
transit amplifying cell | 3 studies | 33% ± 26% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 3998.20 | 245 / 245 | 100% | 80.77 | 502 / 502 |
esophagus | 100% | 1715.46 | 1443 / 1445 | 100% | 17.30 | 183 / 183 |
brain | 100% | 4036.68 | 2642 / 2642 | 100% | 26.91 | 704 / 705 |
breast | 99% | 1656.20 | 456 / 459 | 99% | 21.32 | 1104 / 1118 |
intestine | 100% | 1612.93 | 966 / 966 | 98% | 12.96 | 516 / 527 |
lung | 99% | 1363.81 | 573 / 578 | 99% | 13.42 | 1138 / 1155 |
uterus | 100% | 2009.96 | 170 / 170 | 97% | 14.65 | 447 / 459 |
thymus | 100% | 1333.79 | 651 / 653 | 98% | 12.78 | 591 / 605 |
bladder | 100% | 1689.90 | 21 / 21 | 97% | 11.62 | 487 / 504 |
stomach | 98% | 1059.69 | 353 / 359 | 98% | 14.57 | 280 / 286 |
ovary | 100% | 1988.66 | 180 / 180 | 96% | 11.43 | 413 / 430 |
skin | 100% | 1993.75 | 1807 / 1809 | 93% | 17.33 | 440 / 472 |
kidney | 100% | 1106.02 | 89 / 89 | 89% | 18.16 | 798 / 901 |
pancreas | 69% | 427.63 | 226 / 328 | 99% | 11.09 | 176 / 178 |
adrenal gland | 94% | 807.83 | 242 / 258 | 73% | 6.13 | 167 / 230 |
liver | 85% | 593.98 | 192 / 226 | 58% | 6.23 | 234 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 10.10 | 29 / 29 |
spleen | 100% | 1543.40 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1694.97 | 1333 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 1548.03 | 1200 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 15.56 | 44 / 45 |
peripheral blood | 89% | 1488.05 | 831 / 929 | 0% | 0 | 0 / 0 |
heart | 87% | 670.51 | 746 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 86% | 11.98 | 69 / 80 |
muscle | 79% | 561.96 | 636 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0006468 | Biological process | protein phosphorylation |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_1990508 | Cellular component | CKM complex |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004693 | Molecular function | cyclin-dependent protein serine/threonine kinase activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | CDK19 |
Protein name | Cyclin-dependent kinase 19 (EC 2.7.11.22) (CDC2-related protein kinase 6) (Cell division cycle 2-like protein kinase 6) (Cell division protein kinase 19) (Cyclin-dependent kinase 11) (Death-preventing kinase) Cyclin dependent kinase 19 Cyclin dependent kinase 19 variant 2 |
Synonyms | CDC2L6 CDK11 KIAA1028 |
Description | |
Accessions | ENST00000323817.7 [Q9BWU1-2] ENST00000413605.6 I6W807 ENST00000368911.8 [Q9BWU1-1] ENST00000457688.5 H0YDW9 Q5JQZ9 F6QTA4 ENST00000463016.1 Q9BWU1 |